Can Psychotherapy Reduce Sickness Absence?

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Lovisenberg Diakonale Hospital
ClinicalTrials.gov Identifier:
NCT01181635
First received: August 12, 2010
Last updated: September 11, 2014
Last verified: September 2014
  Purpose

The purpose of this study is to examine if psychotherapy can reduce sickness absence.


Condition Intervention
Mental Disorders
Behavioral: Psychotherapy

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Can Psychotherapy Reduce Sickness Absence?

Resource links provided by NLM:


Further study details as provided by Lovisenberg Diakonale Hospital:

Primary Outcome Measures:
  • Sickness absence [ Time Frame: Before, after and 6 months after treatment. ] [ Designated as safety issue: No ]
    Present status (working or sick).


Secondary Outcome Measures:
  • Psychiatric symptoms [ Time Frame: Before, after and 6 months after treatment. ] [ Designated as safety issue: No ]
    CORE-OM.

  • Quality of life (QALY) [ Time Frame: Before, after and 6 months after treatment. ] [ Designated as safety issue: No ]
    15 D


Estimated Enrollment: 400
Study Start Date: August 2010
Estimated Study Completion Date: July 2015
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Psychotherapy Behavioral: Psychotherapy
Standard psychotherapy for psychiatric disorders.

Detailed Description:

Sickness absence due to psychiatric problems is considered a growing problem in Norway. Little research is done to examine if psychotherapy can reduce sickness absence. Since 2007 there is a government sponsored program in Norway (Raskere tilbake) aimed at reducing sickness absence. This study examines if psychotherapy within this program, delivered at an out-patient clinic, actually reduces sickness absence. Levels of absenteeism is measured before, after and 6 months after treatment. This is a quasi-experimental study, where the treatment-group will be compared with a statistical group in the general population, that is socio-demographical similar and has similar history of sickness absence but haven't been to treatment. Changes in levels of symptoms and quality of life will also be measured. The participants will be asked to describe their working environment, and this will be related to outcome-measures.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving psychotherapy at Lovisenberg DPS/Raskere Tilbake

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01181635

Locations
Norway
Lovisenberg diakonale sykehus, Lovisenberg DPS
Oslo, Norway, 0440
Sponsors and Collaborators
Lovisenberg Diakonale Hospital
Investigators
Study Director: Torleif Ruud, dr.med Akershus universitetssykehus
  More Information

No publications provided

Responsible Party: Lovisenberg Diakonale Hospital
ClinicalTrials.gov Identifier: NCT01181635     History of Changes
Other Study ID Numbers: 2010/494 (REK)
Study First Received: August 12, 2010
Last Updated: September 11, 2014
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on October 01, 2014